CLINICAL_TRIALS
trial_result
· 2023-04-26
Clinical Trial Update: Progesterone Effect on Individuals Diagnoses With AD and PTSD. [Phase 2, Phase 3]
Summary
Phase 2/3 trial evaluating progesterone effects in individuals with alcohol dependence and PTSD; study completed with results posted in 2023.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Yale University | Conditions: Alcohol Dependence, Post-Traumatic Stress Disorder (PTSD) | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2023-04-26